Sign In
20 Mar 2017 15:30
Ā
Ā
Ā
Ā
Ā
20 March 2017
Ā
RECKITT BENCKISER GROUP PLC
("RB" or the "Company")
Ā DIRECTOR/PDMR SHAREHOLDING
Ā
Notification of transactions of Directors/Persons Discharging Managerial Responsibility ("PDMR") in ordinary shares of 10 pence each in the share capital of the Company ("Shares").
Ā
On 20 March 2017, Rob de Groot, Area Executive Vice President ENA, a PDMR, transferred 255,505 Shares to his spouse, Danielle Van Dommelen, by way of a non-market transfer for nil consideration. There was no change in the ultimate beneficial ownership of the Shares as a result of the transfer.
Ā
Following the transaction, Mr de Groot's shareholding (including beneficial interest) is 313,675 Shares, representing 0.0448% of the Company's issued share capital. Treasury shares have not been taken into account when calculating this percentage.
Ā
The following notification is made in accordance with the requirements of the EU Market Abuse Regulation.
Ā
Ā
NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM |
Ā
Ā
1 | Details of the person discharging managerial responsibilities / person closely associated | |||||
a) | Name | Rob de Groot | ||||
2 | Reason for the notification | |||||
a) | Position/status | Ā Area EVP, ENA | ||||
b) | Initial notification/Amendment | Initial notification | ||||
3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||||
a) | Name | Reckitt Benckiser Group plc | ||||
b) | LEI | 5493003JFSMOJG48V108 | ||||
4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||
a) | Description of the financial instrument, type of instrument Identification code | Ordinary Shares of 10p each in Reckitt Benckiser Group plc ("Shares") GB00B24CGK77 | ||||
b) | Nature of the transaction | Non-market transfer of 255,505 Shares from Rob de Groot to Danielle Van Dommelen for nil consideration. No change in beneficial ownership. | ||||
c) | Price(s) and volume(s) | Ā
Ā | ||||
d) | Aggregated information - Aggregated volume - Price | Ā - Ā - | ||||
e) | Date of the transaction | Ā 2017-03-20 | ||||
f) | Place of the transaction | Outside a trading venue | ||||
Ā
Ā
1 | Details of the person discharging managerial responsibilities / person closely associated | |||||
a) | Name | Danielle Van Dommelen | ||||
2 | Reason for the notification | |||||
a) | Position/status | PCA to Rob de Groot | ||||
b) | Initial notification/Amendment | Initial notification | ||||
3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||||
a) | Name | Reckitt Benckiser Group plc | ||||
b) | LEI | 5493003JFSMOJG48V108 | ||||
4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||
a) | Description of the financial instrument, type of instrument Identification code | Ordinary Shares of 10p each in Reckitt Benckiser Group plc ("Shares") GB00B24CGK77 | ||||
b) | Nature of the transaction | Non-market transfer of 255,505 Shares from Rob de Groot to Danielle Van Dommelen for nil consideration. No change in beneficial ownership. | ||||
c) | Price(s) and volume(s) | Ā
Ā | ||||
d) | Aggregated information - Aggregated volume - Price | Ā - Ā - | ||||
e) | Date of the transaction | Ā 2017-03-20 | ||||
f) | Place of the transaction | Outside a trading venue | ||||
Ā
Ā
Ā
For further Information:Christine Logan
Deputy Company SecretaryTel +44 (0) 1753 217 800
Ā
Reckitt Benckiser Group plc's LEI code isĀ 5493003JFSMOJG48V108
Ā
About RB:
Ā
RB* is the world's leading consumer health and hygiene company. The company has operations in over 60 countries, with headquarters in London, Dubai and Amsterdam, and sales in most countries across the globe. The company employs approximately 37,000 people worldwide.
Inspired by a purpose to deliver innovative solutions for healthier lives and happier homes, RB is in the top 20 companies listed on the London Stock Exchange. We are the global No 1 or No 2 in the majority of our fast-growing categories, driven by an exceptional focus on innovation. Our health, hygiene and home portfolio is led by our global Powerbrands including Nurofen, Strepsils, Gaviscon, Mucinex, Durex, Scholl, Clearasil, Lysol, Dettol, Veet, Harpic, Cillit Bang, Mortein, Finish, Vanish, Calgon, Air Wick, Woolite and French's. Our Powerbrands represent 80% of net revenue.
Ā
RB is redefining the world of consumer health and hygiene. Our people and unique culture are at the heart of our success. We have a drive for achievement and a passion to outperform wherever we focus, including sustainability where we are targeting a 1/3 reduction in water impact, 1/3 reduction in carbon and 1/3 of net revenue from more sustainable products. We are proud to be Save the Children's largest global partner, with a new vision to radically reduce one of the world's largest killers of under 5s, diarrhoea.
Ā
For more information visit www.rb.comĀ
Ā
*RB is the trading name of the Reckitt Benckiser group of companies
Ā
Follow the stocks
